The evolving role of inflammation in obesity and the metabolic syndrome
The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Abstract
Advances in adipose tissue biology over the past 10 years have led to an improved understanding of the mechanisms linking obesity with the metabolic syndrome and other complications. Obesity is characterized by a chronic, systemic low-grade state of inflammation. Biomarkers of inflammation, such as the leukocyte count, tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (IL-6), and C-reactive protein, are increased in obesity, associated with insulin resistance, and predict the development of type 2 diabetes and cardiovascular disease. It is now clear that the adipocyte is an active participant in the generation of the inflammatory state in obesity. Adipocytes secrete a variety of cytokines, including IL-6 and TNF-alpha, that promote inflammation. Moreover, recent studies suggest that obesity is associated with an increase in adipose tissue macrophages, which also participate in the inflammatory process through the elaboration of cytokines. An improved understanding of the role of adipose tissue in the activation of inflammatory pathways may suggest novel treatment and prevention strategies aimed at reducing obesity-associated morbidities and mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Metabolic disorders of this type too are closely intertwined with inflammation [575,581,587,638], that is of course stimulated by ROSs whose generation is increased by high-fat diets [639].”
In the citing paper
“considerable evidence suggests that obesity and inflammation are significantly related [163,486,575,581,642,647-664]”
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518 · cited 2×
“Neutralization of TNF-α improved insulin action in an obese rat model [ 17 ] and obese mice deficient in TNF-α and inducible nitric oxide synthase (iNOS) [18,19] showed an increase in insulin sensitivity compared with obese wild-type control animals.”
BackgroundMethodXu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522 · cited 4×
“We now know that adipose tissue is not merely a passive storage depot, but is in fact a complex, metabolically active tissue that secretes a variety of signaling molecules that regulate feeding behavior and energy expenditure, and metabolic, endocrine, and immune function through endocrine, paracrine, and autocrine pa…”
BackgroundResultInfluentialMutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Maffei, M., Halaas, J., Ravussin, E., Pratley, R. E., Lee, G. H., Zhang, Y., Fei, H., Kim, S., Lallone, R., Ranganathan, S., et al. (1995) · Nature Medicine · doi:10.1038/nm1195-1155 · Cited by 3,725 · cited 1×
“We and others demonstrated that leptin was secreted in proportion to the degree of obesity [ 35 ].”
BackgroundSelf-citationWeyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
Self-citationA central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 1×
“JNK-deficient mice are resistant to obesity and are more insulin sensitive than control animals [ 22 ], emphasizing the importance of JNK as a crucial component of the biochemical pathway linking obesity and insulin resistance in vivo.”
BackgroundKim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630 · cited 1×
“Induction of insulin resistance by TNF-α, a potent activator of c-Jun aminoterminal kinase (JNK), involves inhibitory phosphorylation of IRS-1 at Ser 307 [20, 21 ].”
BackgroundElevated C-reactive protein levels in overweight and obese adults
Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234
Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., & Matsubara, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0587 · Cited by 2,083 · cited 1×
“Another key development in adipocyte biology has been the discovery of adiponectin [ 36 ].”
BackgroundYuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Aguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487 · cited 1×
“Induction of insulin resistance by TNF-α, a potent activator of c-Jun aminoterminal kinase (JNK), involves inhibitory phosphorylation of IRS-1 at Ser 307 [ 20 ,21].”
BackgroundRidker, P. M. (2001) · Circulation · doi:10.1161/01.cir.103.13.1813 · Cited by 1,402 · cited 1×
“Large trials have also demonstrated that an increased CRP is a risk factor for cardiovascular events [ 33 ].”
BackgroundBuchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339
Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link
Hotamisligil, G. S., & Spiegelman, B. M. (1994) · Diabetes · doi:10.2337/diab.43.11.1271 · Cited by 1,281 · cited 2×
“Hotamisligil and Spiegelman [ 8 ] and Hotamisligil et al. [17] first proposed a role for the proinflammatory cytokine TNF-α in obesity and insulin resistance.”
Pickup, J. C., Mattock, M. B., Chusney, G. D., & Burt, D. (1997) · Diabetologia · doi:10.1007/s001250050822 · Cited by 1,242
Minireview: The Adipocyte—At the Crossroads of Energy Homeostasis, Inflammation, and Atherosclerosis
Rajala, M. W., & Scherer, P. E. (2003) · Endocrinology · doi:10.1210/en.2003-0580 · Cited by 1,190
Schmidt, M. I., Duncan, B. B., Sharrett, A. R., Lindberg, G., Savage, P. J., Offenbacher, S., Azambuja, M. I., Tracy, R. P., & Heiss, G. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01046-6 · Cited by 1,071
Low-Grade Systemic Inflammation and the Development of Type 2 Diabetes
Duncan, B. B., Schmidt, M. I., Pankow, J. S., Ballantyne, C. M., Couper, D., Vigo, A., Hoogeveen, R., Folsom, A. R., & Heiss, G. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1799 · Cited by 1,036
The Obesity Epidemic: Pathophysiology and Consequences of Obesity
Pi‐Sunyer, F. X. (2002) · Obesity Research · doi:10.1038/oby.2002.202 · Cited by 858 · cited 2×
“manifest elements of the metabolic syndrome, including insulin resistance, hypertension, and dyslipidemia, and are at increased risk for many chronic diseases, including type 2 diabetes, atherosclerosis, certain types of cancer, and respiratory disorders [ 2 ].”
BackgroundMinireview: Adiposity, Inflammation, and Atherogenesis
Lyon, C. J., Law, R. E., & Hsueh, W. A. (2003) · Endocrinology · doi:10.1210/en.2003-0285 · Cited by 761
Castell, J. V., Gómez-lechón, M. J., David, M., Fabra, R., Trullenque, R., & Heinrich, P. C. (1990) · Hepatology · doi:10.1002/hep.1840120517 · Cited by 757
Prevention of fat-induced insulin resistance by salicylate
Kim, J. K., Kim, Y.-J., Fillmore, J. J., Chen, Y., Moore, I., Lee, J., Yuan, M., Li, Z. W., Karin, M., Perret, P., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11559 · Cited by 737
Circulating Interleukin‐6 in Relation to Adiposity, Insulin Action, and Insulin Secretion
Vozarova, B., Weyer, C., Hanson, K., Tataranni, P. A., Bogardus, C., & Pratley, R. E. (2001) · Obesity Research · doi:10.1038/oby.2001.54 · Cited by 639
Self-citationChanging concepts of atherogenesis
Libby, P. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00654.x · Cited by 626 · cited 1×
“At an early stage of the atherosclerotic process, oxidized low-density lipoprotein cholesterol is taken up into macrophages that have migrated into the vascular interstitium from the circulation [ 42 ].”
BackgroundMechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes
Hundal, R. S., Petersen, K. F., Mayerson, A. B., Randhawa, P. S., Inzucchi, S. E., Shoelson, S. E., & Shulman, G. I. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14955 · Cited by 621
Stein, C. J., & Colditz, G. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0288 · Cited by 615 · cited 1×
“The annual direct and indirect costs attributable to obesity exceed $117 billion in the United States alone, and higher rates of obesity are responsible for a substantial proportion of recent increases in health care spending [ 3 ].”
BackgroundVozarova, B., Weyer, C., Lindsay, R. S., Pratley, R. E., Bogardus, C., & Tataranni, P. A. (2002) · Diabetes · doi:10.2337/diabetes.51.2.455 · Cited by 564 · cited 1×
“We recently demonstrated that the risk for developing type 2 diabetes was increased 2.7-fold among those with a leukocyte count in the 90th percentile compared with those in the 10th percentile [ 31 ].”
BackgroundSelf-citationMechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes
Hundal, R. S., Petersen, K. F., Mayerson, A. B., Randhawa, P. S., Inzucchi, S., Shoelson, S. E., & Shulman, G. I. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214955 · Cited by 557
Perreault, M., & Marette, A. (2001) · Nature Medicine · doi:10.1038/nm1001-1138 · Cited by 539
Maffei, M., Fei, H., Lee, G. H., Dani, C., Leroy, P., Zhang, Y., Proenca, R., Negrel, R., Ailhaud, G., & Friedman, J. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6957 · Cited by 465 · cited 1×
“The cloning of leptin, an adipose-specific cytokine-like molecule by Maffei et al. [ 34 ] in 1995, dramatically changed the prevailing view of the role of adipose tissue in obesity.”
BackgroundCollins, A. R., Meehan, W. P., Kintscher, U., Jackson, S., Wakino, S., Noh, G., Palinski, W., Hsueh, W. A., & Law, R. E. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.3.365 · Cited by 385 · cited 1×
“high-risk Hispanic women [45], and inhibited formation of early atherosclerotic lesions in low-density lipoprotein receptor–deficient mice fed a high-fat diet [ 46 ].”
BackgroundDistinct Transcriptional Profiles of Adipogenesisin Vivo and in Vitro
Soukas, A., Socci, N. D., Saatkamp, B. D., Novelli, S., & Friedman, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104421200 · Cited by 368 · cited 1×
“Soukas et al. [ 39 ] showed large differences in gene expression between fractions by comparing gene expression in isolated adipocytes and the SVC fraction (containing preadipocytes and other cell types).”
BackgroundWhite blood cell count and cardiovascular disease. Insights from the Framingham Study
Kannel, W. B. (1992) · JAMA · doi:10.1001/jama.267.9.1253 · Cited by 365
Müller, S., Martin, S., Koenig, W., Hanifi-Moghaddam, P., Rathmann, W., Haastert, B., Giani, G., Illig, T., Thorand, B., & Kolb, H. (2002) · Diabetologia · doi:10.1007/s00125-002-0829-2 · Cited by 311
Adipose tissue, insulin action and vascular disease: inflammatory signals
Yudkin, J. S. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802496 · Cited by 311
Leinonen, E., Hurt-Camejo, E., Wiklund, O., Hultén, L. M., Hiukka, A., & Taskinen, M.-R. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00371-4 · Cited by 274 · cited 1×
“It is, itself, increased in obesity [12], as are other acute-phase reactant proteins, including serum amyloid A and fibrinogen [ 13 ,14].”
BackgroundCHRYSOHOOU, C. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.03.675 · Cited by 233
Weyer, C., Yudkin, J. S., Stehouwer, C. D. A., Schalkwijk, C. G., Pratley, R. E., & Tataranni, P. A. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00626-8 · Cited by 211 · cited 3×
“We also demonstrated that elevated CRP levels were associated with insulin resistance, a relation that was not entirely explained by obesity [ 12 ].”
BackgroundSelf-citationWeyer, C., Tataranni, P. A., & Pratley, R. E. (2000) · Diabetes Care · doi:10.2337/diacare.23.6.779 · Cited by 121 · cited 2×
“As suggested earlier, several studies have demonstrated an association between insulin resistance and markers of inflammation, such as an increased leukocyte and circulating plasma IL-6 and TNF-α concentrations [6,7,12, 15 ,16].”
BackgroundSelf-citationWeinhold, B., Bader, A., Poli, V., & Rüther, U. (1997) · Biochemical Journal · doi:10.1042/bj3250617 · Cited by 103
Relation of the White Blood Cell Count to Obesity and Insulin Resistance: Effect of Race and Gender
Pratley, R. E., Wilson, C., & Bogardus, C. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00191.x · Cited by 80
Self-citationKaplan, R. C., & Frishman, W. H. (2001) · Heart Disease · doi:10.1097/00132580-200109000-00009 · Cited by 67
Troglitazone Improves Endothelial Dysfunction in Patients with Insulin Resistance
Watanabe, Y., Sunayama, S., Shimada, K., Sawano, M., Hoshi, S.-I., Iwama, Y., Mokuno, H., Daida, H., & Yamaguchi, H. (2000) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.7.159 · Cited by 61
Gene expression profiling of adipose tissue:
Klaus, S., & Keijer, J. (2003) · Nutrition · doi:10.1016/j.nut.2003.09.020 · Cited by 47
Nagi, D. K., Tracy, R. P., & Pratley, R. E. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90242-5 · Cited by 26 · cited 2×
“As suggested earlier, several studies have demonstrated an association between insulin resistance and markers of inflammation, such as an increased leukocyte and circulating plasma IL-6 and TNF-α concentrations [6,7,12,15, 16 ].”
BackgroundSelf-citation
Cited by
Abel, E. D., Litwin, S. E., & Sweeney, G. (2008) · Physiological Reviews · doi:10.1152/physrev.00017.2007 · Cited by 736
“There is ever-increasing interest in the link between obesity and inflammation (78, 80, 204, 221), and an inflammatory state is both a causative factor in inducing MI and a primary constituent of the response to MI (210, 341, 385).”
BackgroundKell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“ther diseases we review here, studies of pro-inflammatory markers (such as TNF-α, IL-1 and C-reactive protein [485]) during the development of diabetes show its aetiology to be inflammatory in nature [468; 486, 487, 488, 489, 490, 491, 492, 493, 494, 495, 496, 497, 498, 499, 500, 501, 502, 503, 504, 505]. Iron ‘excess…”
BackgroundExercise as a Mean to Control Low‐Grade Systemic Inflammation
Mathur, N., & Pedersen, B. K. (2008) · Mediators of Inflammation · doi:10.1155/2008/109502 · Cited by 514
“The systemic response known as the acute-phase response includes the production of a large number of hepatocyte-derived acute phase proteins, such as C-reactive protein (CRP) that is known to be a sensitive marker of systemic inflammation.”
BackgroundObesity, inflammation, and liver cancer
Sun, B., & Karin, M. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.09.020 · Cited by 496
“The connection between obesity and cancer is likely to be mediated, in part, by a state of chronic low-grade inflammation in the involved tissues [5–10].”
BackgroundObesity and migraine: A population study
Bigal, M. E., Liberman, J. N., & Lipton, R. B. (2006) · Neurology · doi:10.1212/01.wnl.0000197218.05284.82 · Cited by 370
Metadata
- Authors
- Lee, Y.-H., & Pratley, R. E.
- Affiliations
- University of Vermont (US)
- Venue
- Current Diabetes Reports
- Published
- 2005-01
- Volume
- 5
- Issue
- 1
- Pages
- 70-75
- ISSN
- 1534-4827 (ISSN-L)
- 1539-0829
- OpenAlex
- W2147375465
- Cited by
- 369
- References
- 53
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 9 · 2023: 15 · 2022: 15 · 2021: 11 · 2020: 15 · 2019: 10 · 2018: 15 · 2017: 22 · 2016: 17 · 2015: 21 · 2014: 31 · 2013: 15 · 2012: 21
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Diabetes Reports (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- obesity, metabolic syndrome, low-grade inflammation, adipose tissue, adipocytes, adipose tissue macrophages, cytokines, TNF-α, interleukin-6, C-reactive protein, insulin resistance, type 2 diabetes, cardiovascular disease, inflammatory markers
- MeSH terms
- Arteriosclerosis, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Humans, Inflammation, Insulin Resistance, Obesity, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.